Code | Name |
---|---|
F1100602 | Cell receptors |
F1100601 | Autonomic nervous system |
F1100699 | Other neurosciences n.e.c. |
F1100618 | Neuropsychiatry |
F1100617 | Sleep disorders |
F1100616 | Degenerative diseases |
F1100615 | Head injury |
F1100614 | Migraine |
F1100613 | Epilepsy |
F1100612 | Cerebral vascular disorder |
F1100610 | Psychogeriatrics |
F1100609 | Auditory neuroscience |
F1100608 | Sensory systems |
F1100607 | Peripheral nervous system |
F1100606 | Molecular characterization |
F1100605 | Mechanism of tissue damage |
F1100604 | Central nervous system |
F1100603 | Cellular nervous system |
F1100611 | Cerebral palsy |
Code | Name | Scope Note |
---|---|---|
F1101112 | Health technology assessments | |
F1101113 | Home care services | |
F1101114 | Human resource development | sn: including technologies in attitude determination control instruments |
F1101115 | Innovative technology | |
F1101116 | Medical biotechnology | |
F1101117 | Programme evaluation | |
F1101118 | Quality assurance of health instruments | |
F1101119 | Quality of life | |
F1101120 | Standards and calibration | |
F1101121 | Assistive technology | |
F1101199 | Other health care system, industries and technologies n.e.c. | |
F1101111 | Health rehabilitation service | |
F1101110 | Health policy analysis | |
F1101109 | Health outcomes | |
F1101108 | Health legislation | |
F1101107 | Health information management | |
F1101106 | Health care financing | |
F1101105 | Equity | |
F1101104 | Delivery systems | |
F1101103 | Continuous quality improvement | |
F1101102 | Burden of disease | |
F1101101 | Biomechanics |